|
Volumn 363, Issue 2, 2001, Pages 215-221
|
Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway
|
Author keywords
Apoptosis; Oral antidiabetics; Oral hypoglycemic agents; Peroxisome proliferator activated receptor ; Rosiglitazone; Signal regulated response kinases; Smooth muscle; Thiazolidinediones; Troglitazone
|
Indexed keywords
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
CASPASE 3;
DNA FRAGMENT;
MITOGEN ACTIVATED PROTEIN KINASE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ROSIGLITAZONE;
TROGLITAZONE;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
CELL COUNT;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG ANTAGONISM;
DRUG INHIBITION;
ENZYME ACTIVITY;
NONHUMAN;
RAT;
VASCULAR SMOOTH MUSCLE;
WESTERN BLOTTING;
ANIMALS;
APOPTOSIS;
CELLS, CULTURED;
CHROMANS;
FIBRINOLYTIC AGENTS;
MITOGEN-ACTIVATED PROTEIN KINASES;
MUSCLE, SMOOTH, VASCULAR;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHORYLATION;
RATS;
RATS, INBRED WKY;
THIAZOLES;
THIAZOLIDINEDIONES;
|
EID: 0035089354
PISSN: 00281298
EISSN: None
Source Type: Journal
DOI: 10.1007/s002100000352 Document Type: Article |
Times cited : (34)
|
References (31)
|